Anyone who's been involved here, especially holding large amounts, knows patience well. MMs may have to chase..

Strategically positioned to take advantage of the increasing demand for copper, Libero Copper (LBC.v, LBMF) is focused on developing theMocoa Project in Colombia, a significant copper-molybdenum deposit containing 630 million tons of resources with a copper grade of 0.33%.

As detailed

10 MILLION $ICBU SHARES X .005 =$50,000

Then who sold the shares?
Who has buy range between 4 to 46
Be patient

$ALCE under $2 next week JMHO

Big monster more 300% one day
Congrat for all trader

Yes, what's the point?

Exactly. There are 41,000 active and inactive claims just in the county of Inyo that the mill is in. With gold closing in on $2700 an ounce watch that inactive claim number really start climbing up in my opinion!

I added a few more, let's see if we can push up above .03 today.

Damn I added a few this is a real company I really don't think it will need pumping 

Icing on the cake will be a nice update after close.....come on Dr. Korenko.....talk to us.....

Lmao. No one manipulating. Tried to warn you folks. Take care

Late in the day, but the HOD looks to be in..Maybe a down day Monday?



https://schrts.co/jUHYXvyQ

.041 next week easy

I am in a firefighter group that has quite a few australian members. They are saying that the fire season is really getting off to a slow start over there. And posting training material, this one is of spiders to watch out for in your part of the world. Good thing they have a sense of humor.

RD Thanks! I was not aware of this. It means that Laxmi has changed his plans in a way that seems sensible to me. Before the plan was to transfer the money to Hong Kong to get the sum doubled as far as I remember.

Its criminal how they are manipulating this stock...

No one dishes out $65M dollars for no reason!

RDAR 1.17B VOLUME 10 DAY AVG_141M .0019 +322.22%

Is that from the Grapevine, . .
. . . or is that just an - educated opinion ?

~ $WDLF ~

👀 entertainment today!

TD Cowen maintained a positive stance on Halozyme (NASDAQ:HALO) Therapeutics (NASDAQ:HALO), reiterating a Buy rating with a $70.00 price target. The firm addressed recent concerns regarding the potential decrease in royalties for Vyvgart, stating that worries are overstated.

https://

asking . 03 with 15 min to go!